Preliminary clinical screening with daunorubicin in lung cancer.
D000230:Adenocarcinoma / Q000188:drug therapy; D000368:Aged; D002283:Carcinoma, Bronchogenic / Q000188:drug therapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D003630:Daunorubicin / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
D003630:Daunorubicin